Symbionics
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Symbionics - overview
Established
2023
Location
Beijing, -, China
Primary Industry
Medical Devices & Equipment
About
Based in Beijing, China, and founded in 2023, Symbionics is a medical equipment company mainly engaged in developing flexible brain-computer interface devices. The founding team members graduated from Harvard University, Massachusetts Institute of Technology, and Columbia University. Xiaochuan Dai, the chief scientist of the company, and CTO Teng Gao have been involved in the field of flexible neural electrodes. In October 2023, Symbionics raised CNY 30 million in angel funding from new investor Kunlun VC.
The company is committed to the research, development, and transformation of brain-computer interface technology in brain science research and clinical applications. The brain-computer interface technology can provide treatment options for various diseases in medical treatment.
Current Investors
Shanhai Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare IT, Medical Devices & Equipment, Hardware
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.